These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26823620)

  • 1. Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
    Teibel HM; Knoderer CA; Nichols KR
    Hosp Pharm; 2015 Sep; 50(8):710-3. PubMed ID: 26823620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations.
    Nichols KR; Demarco MW; Vertin MD; Knoderer CA
    Hosp Pharm; 2013 Jan; 48(1):44-7. PubMed ID: 24421422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.
    Wade J; Cooper M; Ragan R
    Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
    Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW
    Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140
    [No Abstract]   [Full Text] [Related]  

  • 5. Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
    Meyer K; Santarossa M; Danziger LH; Wenzler E
    Hosp Pharm; 2017 Mar; 52(3):221-228. PubMed ID: 28439137
    [No Abstract]   [Full Text] [Related]  

  • 6. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
    Thompson DF; Stiles ML; Allen LV; Tu YH
    Am J Hosp Pharm; 1988 Jan; 45(1):142-5. PubMed ID: 3348228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
    Katip W
    Am J Health Syst Pharm; 2017 Jul; 74(14):1099-1102. PubMed ID: 28687555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration.
    Sullivan T; Forest JM; Leclair G
    Hosp Pharm; 2015 Mar; 50(3):214-20. PubMed ID: 26405311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.
    Berti AD; Hutson PR; Schulz LT; Webb AP; Rose WE
    Am J Health Syst Pharm; 2015 Mar; 72(5):390-5. PubMed ID: 25694414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
    Lee TM; Villareal CL; Meyer LM
    Hosp Pharm; 2021 Aug; 56(4):282-286. PubMed ID: 34381262
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy.
    Joiner LC; Tynes C; Arnold J; Miller RR; Gorman G
    Hosp Pharm; 2018 Apr; 53(2):125-127. PubMed ID: 29581608
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
    Correard F; Savry A; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Aug; 71(15):1288-91. PubMed ID: 25027536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
    Fox LM; Wilder AG; Foushee JA
    Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.
    Najari Z; Rusho WJ
    Am J Health Syst Pharm; 1997 Jan; 54(2):181-4. PubMed ID: 9117807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
    Hutchings SR; Rusho WJ; Tyler LS
    Am J Health Syst Pharm; 1996 Sep; 53(18):2185-8. PubMed ID: 8879326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.